Kallikrein 7 antibody (AA 1-200)
Quick Overview for Kallikrein 7 antibody (AA 1-200) (ABIN7868615)
Target
See all Kallikrein 7 (KLK7) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-200
-
Purpose
- KLK7 Antibody / Kallikrein 7
-
Purification
- Protein A/G affinity
-
Immunogen
- A recombinant fragment of human KLK7 protein (within amino acids 1-200) was used as the immunogen for the KLK7 antibody.
-
Isotype
- IgG2b, kappa
-
-
-
-
Application Notes
- Optimal dilution of the KLK7 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the KLK7 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Kallikrein 7 (KLK7)
-
Alternative Name
- KLK7
-
Background
- Kallikreins (KLKs) belong to the serine protease family of proteolytic enzymes. Human pancreatic/renal KLK encodes for the KLK1 enzyme, which is involved in post-translational processing of polypeptide precursors. The function of the other members of KLK gene family is currently unknown, but evidence suggests that many KLKs are implicated in carcinogenesis. The human KLK gene family consists of 15 serine proteases. The human KLK genes are clustered on chromosome 19q13.41. Unlike other kalllikreins, the KLK4-15 encoded proteases are less related and do not contain a conventional KLK loop. Clusters of genes exhibit high prostatic (KLK2-4, KLK15) or pancreatic (KLK6-13) expression. KLK2 is also known as glandular kallikrein 2, tissue kallikrein or HGK-1, and KLK3 is known as prostate-specific antigen (PSA). Both KLK2 and KLK3 have important applications in prostate cancer and breast cancer diagnostics. KLK4, KLK5, KLK9, KLK13, KLK12 and KLK14 have been previously known as KLK-L1, KLK-L2, KLK-L3, KLK-L4, KLK-L5 and KLK-L6, respectively. Many of the KLKs are regulated by steroid hormones and a few of them, specifically KLK3, KLK6 and KLK10, are known to be downregulated in breast and other cancers.
-
UniProt
- P49862
-
Pathways
- Complement System
Target
-